Alimera Sciences Inc.
ALIM
Get informed when a big investor buys or sells
+ FollowMarket Cap$301.29M
Close$
$7.08
27.7% upside
Current Fair Value
27.7% upsideUndervalued by 27.7% based on the discounted cash flow analysis.
Share Statistics
| Market cap | $301.29 Million |
|---|---|
| Enterprise Value | $360.65 Million |
| Dividend Yield | $- (-) |
| Earnings per Share | $-0.79 |
| Beta | 1.25 |
| Outstanding Shares | 54,384,000 |
Return
| Return on Equity | -37.89% |
|---|---|
| Return on Assets | -9.77% |
| Return on Invested Capital | -3.43% |
Valuation & Multiples
| P/E Ratio | -7.03 |
|---|---|
| PEG | 10.5 |
| Price to Sales | 5.54 |
| Price to Book Ratio | - |
| Enterprise Value to Revenue | 3.62 |
| Enterprise Value to EBIT | -80.5 |
| Enterprise Value to Net Income | -25 |
| Total Debt to Enterprise | 0.19 |
| Debt to Equity | 1.81 |
Revenue Sources
No data
Insider Trades
Institutional Sentiment (Put/Call)
No data available for the latest quarter.
Institutional Ownership
No data available for the latest quarter.
ESG Score
No data
About Alimera Sciences Inc.
CEO: Richard Eiswirth